About ETX-636
Who Qualifies
What to Expect
Study Details
Locations
FAQs

Select Page

MailPoet Page

by | May 8, 2026

[mailpoet_page]

Related

About ETX-636
Who Qualifies
What to Expect
Study Details
Locations
FAQs

ClinicalTrials.gov Study Identifier: NCT06993844
Link: Study Details | NCT06993844 | Phase 1/2 Study of ETX-636 in Participants With Advanced Solid Tumors | ClinicalTrials.gov

©2026 Ensem. All rights reserved.

Designed by TellMed Strategies

🌐 This website is intended only for use in the U.S.